查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
乳癌治療市場規模和預測、全球和區域佔有率、趨勢和成長機會分析報告範圍：按藥物治療、乳癌類型、配銷通路和地理位置
市場調查報告書
商品編碼
1372542

乳癌治療市場規模和預測、全球和區域佔有率、趨勢和成長機會分析報告範圍：按藥物治療、乳癌類型、配銷通路和地理位置

Breast Cancer Therapeutics Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy, Breast Cancer Type, Distribution Channel, and Geography
出版日期: | 出版商: The Insight Partners | 英文 204 Pages | 訂單完成後即時交付

價格

乳癌治療市場規模和預測（2020-2030）、全球和地區佔有率、趨勢和成長機會分析

承保範圍：藥物治療[標靶藥物治療（Abemaciclib、Ado-Trastuzumab Emtansine、Palbociclib、曲妥珠單抗和其他標靶藥物治療）、荷爾蒙藥物治療（選擇性雌激素受體調節劑、芳香酶抑制劑和選擇性雌激素受體下調劑）、化療和免疫治療/生物治療]、乳癌類型（荷爾蒙受體、HER2+和三陰性乳癌）、配銷通路（醫院藥房、藥房和零售藥房、網路藥房）以及地理位置（北美洲、歐洲、亞太地區、中東和非洲、南美洲和中美洲）

乳癌治療市場規模預計將從2022年的310.7352億美元成長到2030年的639.6705億美元；預計2022年至2030年年複合成長率為9.4%。

乳癌是指乳房細胞增生失控。乳癌有多種形式。哪些乳腺細胞發展成癌症決定了乳癌的類型。導管或小葉是大多數乳癌的起始部位。血管和淋巴管是乳癌轉移到乳房外的兩種方式。其治療取決於癌症的階段。它可能包括化療、放療、荷爾蒙治療和手術。乳癌治療市場的成長歸因於乳癌負擔的增加以及多項診斷和篩檢計畫的推出。

個人化醫療涉及根據個別患者的基因組成等因素制定治療計劃。這種方法考慮到每位患者癌症的獨特特徵，因此可以實現高度針對性和有效的治療。基因組學和分子診斷的進步使個人化醫療成為乳癌治療的可行選擇。醫療保健提供者可以透過在分子層面分析患者的腫瘤來識別驅動癌症生長的特定基因突變或生物標記。然後可以使用這些資訊來選擇最合適的治療方案，例如可能對特定患者最有效的標靶療法或免疫療法。在乳癌治療中使用個人化醫療有可能顯著改善患者的治療效果。例如，2022 年2 月，NIH 研究人員開發了一種個人化乳癌治療方法，這是一種實驗形式的免疫療法，利用患者的抗腫瘤免疫細胞來治療轉移性乳癌患者，從而推進個人化醫療。

透過為個別患者提供量身定做的治療，醫療保健提供者可以增加成功結果的可能性並降低不必要的副作用的風險。除了改善患者的治療效果外，個人化醫療還可以帶來經濟效益。透過選擇更有可能有效的治療方法，醫療保健提供者可以減少與無效治療相關的醫療費用，並避免不必要的費用。隨著基因組學和分子診斷的進步，個人化醫療可能在未來幾年變得越來越容易獲得並融入標準治療方案。因此，個人化醫療的日益普及預計將為乳癌治療市場帶來新的成長趨勢。

基於配銷通路的見解

根據配銷通路，乳癌治療市場分為醫院藥房、藥局和零售藥房以及網路藥房。 2022年，醫院藥局部門佔據最大的市場佔有率。醫院藥局在乳癌治療的管理中發揮著至關重要的作用。他們負責配製和配藥、監測藥物安全、藥物管理、病患教育和其他因素。乳癌是全世界最常見的癌症之一，對有效治療方法的需求正在穩步成長。醫院藥局負責購買、儲存和分發化療藥物和其他與乳癌相關的治療藥物，以確保患者及時接受正確的治療。這些藥局也有權管理這些藥品的庫存和儲存，確保它們按照嚴格的規定儲存和處理。他們與腫瘤學家和醫療團隊的合作確保乳癌患者在整個治療過程中獲得最佳的個人化治療和全面護理。醫院藥房在提供及時有效的乳癌治療方面仍然發揮著重要作用，顯著影響患者對抗疾病的結果。

然而，線上藥局領域預計在 2022 年至 2030 年期間年複合成長率最高。網路藥局提供各種乳癌藥物，從化療藥物到支持療法，通常也提供上門送貨服務。確保處方驗證和維持監管合規性，線上藥局在維護醫療保健系統的完整性方面發揮著至關重要的作用。它們也為喜歡離散購物或因治療而行動不便的患者提供了便利。它們還使患者能夠比較價格並獲得更廣泛的乳癌治療選擇。透過送貨上門和患者支援等服務，線上藥局不斷發展，改變了乳癌治療體驗，並打破了全球患者的地理障礙。此外，越來越多的患者轉向這些藥房獲取治療藥物，因為它們使用起來更方便，這也推動了該領域的成長。

歐洲是市場第二大主導地區。乳癌是英國常見的癌症。根據英國國家醫療服務體系 (NHS)的資料，大約七分之一的女性在一生中被診斷出罹患乳癌。每年約有 55,000 名女性被診斷出罹患乳癌。

醫療產業對新療法治療乳癌患者的更大需求導致了研發投資的增加，從而推動了市場的成長。公司投資研發以保持競爭力並為客戶提供尖端和創新產品。 2021 年 10 月，一種新的抗體療法 Trodelvy 被授權在該國治療一種名為「三陰性乳癌」的侵襲性癌症。 2021年11月，賽諾菲投資1.8億美元，與從事四種癌症發現和開發項目的法美AI新創公司Owkin達成新的策略合作，總支付額達9,000萬美元。此次合作支持賽諾菲在乳癌、肺癌和多發性骨髓瘤等核心領域開發腫瘤產品組合，以加強臨床試驗設計並檢測疾病和治療結果的預測生物標記。

義大利政府和國家衛生機構發起了多項乳癌早期發現和治療措施。這些計劃包括為 50-69 歲女性提供免費乳房 X 光檢查以及全國性乳癌篩檢計劃。 In addition, as per the information provided by EURACTIV, the country has witnessed a strong rise in the number of specialized Breast Units, from 84 in 2012 to 173 in 2020. The country's growing number of breast units helps healthcare professionals offer treatment to patients with乳癌.因此，上述因素支持了該地區的市場成長。

美國癌症協會、世界衛生組織 (WHO)、美國國立衛生研究院和美國 FDA 是準備乳癌治療市場報告時參考的主要和次要來源。

目錄

第 1 章：簡介

  • Insight Partners 研究報告指南
  • 市場區隔

第 2 章：執行摘要

  • 重要見解

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：乳癌治療市場格局

  • 概述
  • PEST分析
    • 全球PEST分析

第 5 章：乳癌治療市場 - 主要產業動態

  • 主要市場促進因素
    • 乳癌負擔日益加重
    • 啟動多項診斷和篩檢項目
  • 主要市場限制
    • 診療費用高
  • 主要市場機會
    • 政府和私人組織增加支持
  • 未來主要趨勢
    • 越來越多使用個人化醫療
  • 影響分析：

第 6 章：乳癌治療市場 - 全球市場分析

  • 乳癌治療市場收入，2022-2030

第 7 章：全球乳癌治療市場收入與 2030 年藥物治療預測

  • 概述
  • 2022 年和 2030 年按藥物治療分類的乳癌治療市場收入佔有率 (%)
  • 標靶藥物治療
  • 荷爾蒙藥物治療
  • 化療
  • 免疫療法/生物療法

第 8 章：按乳癌類型分類的全球乳癌治療市場收入和 2030 年預測

  • 概述
  • 2022 年和 2030 年按乳癌類型分類的乳癌治療市場收入佔有率 (%)
  • 荷爾蒙受體
  • HER2+（人類表皮生長因子受體2）
  • 三陰性乳癌

第 9 章：按配銷通路分類的 2030 年全球乳癌治療市場收入和預測

  • 概述
  • 2022 年和 2030 年乳癌治療市場收入佔有率（按配銷通路）（%）
  • 醫院藥房
  • 藥局和零售藥局
  • 網路藥局

第 10 章：乳癌治療市場 - 地理分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 中東和非洲其他地區
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地區

第 11 章：乳癌治療市場—產業格局

  • 概述
  • 乳癌治療市場的成長策略
  • 有機成長策略
    • 概述
  • 無機成長策略
    • 概述

第 12 章：公司簡介

  • Eli Lilly and Co
  • Eisai Co Ltd
  • Novartis AG
  • AstraZeneca Plc
  • Pfizer Inc
  • Gilead Sciences Inc
  • Merck & Co Inc
  • Genentech Inc.
  • Teva Pharmaceutical Industries Ltd
  • Amgen Inc

第 13 章：附錄

  • 關於我們
  • 專業術語
Product Code: TIPRE00030059

Breast Cancer Therapeutics Market Size and Forecast (2020-2030), Global and Regional Share, Trends, and Growth Opportunity Analysis

Coverage: Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)

The breast cancer therapeutics market size is expected to grow from US$ 31,073.52 million in 2022 to US$ 63,967.05 million by 2030; it is estimated to record a CAGR of 9.4% during 2022 to 2030.

Breast cancer is when the breast's cells proliferate out of control. Breast cancer comes in several forms. Which breast cells develop into cancer determines the type of breast cancer. The ducts or lobules are where most breast cancers start. Blood and lymph vessels are two ways breast cancer can travel outside the breast. Its treatment depends on the stage of cancer. It may consist of chemotherapy, radiation, hormone therapy and surgery. The breast cancer therapeutics market growth is attributed to the growing burden of breast cancer and launch of several diagnostics and screening programs.

Personalized medicine involves tailoring treatment plans to individual patients on the basis of their genetic makeup, among other factors. This approach allows for highly targeted and effective treatments, as it considers the unique characteristics of each patient's cancer. Advancements in genomics and molecular diagnostics have made personalized medicine a viable option in breast cancer treatment. Healthcare providers can identify specific genetic mutations or biomarkers driving the cancer's growth by analyzing a patient's tumor at a molecular level. This information can then be used to select the most appropriate treatment options, such as targeted therapies or immunotherapies, that are likely to be the most effective for that particular patient. The use of personalized medicine in breast cancer therapeutics has the potential to significantly improve patient outcomes. For instance, in February 2022, NIH researchers developed a personalized breast cancer therapy approach, an experimental form of immunotherapy that uses a patient's tumor-fighting immune cells to treat those with metastatic breast cancer, advancing personalized medicine.

By providing tailored treatments to individual patients, healthcare providers can increase the likelihood of successful outcomes and reduce the risk of unnecessary side effects. In addition to improving patient outcomes, personalized medicine also offers economic benefits. By selecting treatments that are more likely to be effective, healthcare providers can reduce healthcare costs associated with ineffective treatments and avoid unnecessary expenses. As advancements in genomics and molecular diagnostics progress, personalized medicine is likely to become increasingly accessible and integrated into standard treatment protocols in the coming years. Therefore, the increasing use of personalized medicine is anticipated to bring new growth trends in the breast cancer therapeutics market.

Distribution Channel -Based Insights

Based on distribution channel, the breast cancer therapeutics market is segmented into hospital pharmacies, drug stores and retail pharmacies, and online pharmacies. The hospital pharmacies segment held the largest market share in 2022. The hospital pharmacy plays a crucial role in the management of breast cancer therapeutics. They are responsible for compounding and dispensing, monitoring drug safety, medication management, educating patients, and other factors. Breast cancer is one of the most widespread cancers worldwide, and the demand for effective therapeutics is steadily increasing. Hospital pharmacies are responsible for procuring, storing, and dispensing chemotherapy medications and other treatments related to breast cancer to ensure that patients receive the right treatment in time. These pharmacies are also in authority to manage the inventory and storage of these drugs, ensuring that they are stored and handled in accordance with strict regulations. Their collaborative efforts with oncologists and healthcare teams ensure that breast cancer patients receive optimal, personalized therapeutics and comprehensive care throughout their treatment journey. Hospital pharmacies remain instrumental in delivering timely and effective breast cancer treatments, significantly impacting patients' outcomes in battling the disease.

However, the online pharmacies segment is anticipated to register the highest CAGR during 2022-2030. Online pharmacies offer a wide array of breast cancer medications ranging from chemotherapy drugs to supportive therapies, often with home delivery services. Ensuring prescription verification and maintaining regulatory compliance, online pharmacies play a vital role in upholding the integrity of the healthcare system. They also provide convenience for patients who prefer discrete shopping or have limited mobility due to treatment. They also enable patients to compare prices and access a broader selection of breast cancer therapeutics. With services such as home delivery and patient support, online pharmacies continue to evolve, transforming the breast cancer treatment experience and breaking down geographical barriers for patients worldwide. In addition, an increasing number of patients have shifted to these pharmacies to acquire therapeutics due to their greater ease in terms of usage, which is fueling the growth of the segment.

Europe is the second leading region in the market. Breast cancer is a common type of cancer in the UK. As per the National Health Service (NHS), about one in seven women are diagnosed with breast cancer during their lifespan in Great Britain data. Each year, ~55,000 women are diagnosed with breast cancer.

Greater demand from the medical industry to treat breast cancer patients with novel therapeutics has led to greater investment in R&D, fueling the growth of the market. Companies invest in research and development to stay competitive and provide customers with cutting-edge and innovative products. In October 2021, Trodelvy, a new antibody treatment, was authorized to treat an aggressive form of cancer called 'triple-negative breast cancer' in the country. In November 2021, Sanofi invested US$ 180 million and entered into a new strategic collaboration with Owkin, a French-American AI start-up engaged in the discovery and development programs of four types of cancer, with a total payment of US$ 90 million. The collaboration supported Sanofi's developing oncology portfolio in core areas such as breast cancer, lung cancer, and multiple myeloma to enhance clinical trial design and detect predictive biomarkers for diseases and treatment results.

The Italian government and national health institutes have launched several initiatives for the early detection and treatment of breast cancer. These programs include free mammograms for women aged 50-69 and a nationwide breast cancer screening program. In addition, as per the information provided by EURACTIV, the country has witnessed a strong rise in the number of specialized Breast Units, from 84 in 2012 to 173 in 2020. The country's growing number of breast units helps healthcare professionals offer treatment to patients with breast cancer. Thus, the abovementioned factors support the market growth in the region.

The American Cancer S0ociety, World Health Organization (WHO), National Institutes of Health, and US FDA are among the primary and secondary sources referred to while preparing the breast cancer therapeutics market report.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the breast cancer therapeutics market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global breast cancer therapeutics market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Breast Cancer Therapeutics Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 Global PEST Analysis

5. Breast Cancer Therapeutics Market - Key Industry Dynamics

  • 5.1 Key Market Drivers
    • 5.1.1 Growing Burden of Breast Cancer
    • 5.1.2 Launch of Several Diagnostics and Screening Programs
  • 5.2 Key Market Restraints
    • 5.2.1 High Cost of Diagnosis and Treatment
  • 5.3 Key Market Opportunities
    • 5.3.1 Increased Support from Government and Private Organizations
  • 5.4 Key Future Trends
    • 5.4.1 Increasing Use of Personalized Medicine
  • 5.5 Impact Analysis:

6. Breast Cancer Therapeutics Market - Global Market Analysis

  • 6.1 Breast Cancer Therapeutics Market Revenue (US$ Mn), 2022 2030

7. Global Breast Cancer Therapeutics Market Revenue and Forecast to 2030 by Drug Therapy

  • 7.1 Overview
  • 7.2 Breast Cancer Therapeutics Market Revenue Share, by Drug Therapy, 2022 & 2030 (%)
  • 7.3 Targeted Drug Therapy
    • 7.3.1 Overview
    • 7.3.2 Targeted Drug Therapy: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)
      • 7.3.2.1 Global Breast Cancer Therapeutics Market, by Targeted Drug Therapy, 2020 - 2030 (US$ Million)
  • 7.4 Hormonal Drug Therapy
    • 7.4.1 Overview
    • 7.4.2 Hormonal Drug Therapy: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Chemotherapy
    • 7.5.1 Overview
    • 7.5.2 Chemotherapy: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Immunotherapy/ Biological Therapy
    • 7.6.1 Overview
    • 7.6.2 Immunotherapy/ Biological Therapy: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)

8. Global Breast Cancer Therapeutics Market Revenue and Forecast to 2030 by Breast Cancer Type

  • 8.1 Overview
  • 8.2 Breast Cancer Therapeutics Market Revenue Share, by Breast Cancer Type, 2022 & 2030 (%)
  • 8.3 Hormone Receptor
    • 8.3.1 Overview
    • 8.3.2 Hormone Receptor: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)
  • 8.4 HER2+ (human epidermal growth factor receptor 2)
    • 8.4.1 Overview
    • 8.4.2 HER2+: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Triple-Negative Breast Cancer
    • 8.5.1 Overview
    • 8.5.2 Triple-Negative Breast Cancer: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)

9. Global Breast Cancer Therapeutics Market Revenue and Forecast to 2030 by Distribution Channel

  • 9.1 Overview
  • 9.2 Breast Cancer Therapeutics Market Revenue Share, by Distribution Channel, 2022 & 2030 (%)
  • 9.3 Hospital Pharmacies
    • 9.3.1 Overview
    • 9.3.2 Hospital Pharmacies: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Drug Store and Retail Pharmacies
    • 9.4.1 Overview
    • 9.4.2 Drug Store and Retail Pharmacies: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Online Pharmacies
    • 9.5.1 Overview
    • 9.5.2 Online Pharmacies: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)

10. Breast Cancer Therapeutics Market - Geographical Analysis

  • 10.1 North America Breast Cancer Therapeutics Market, Revenue and Forecast To 2030
    • 10.1.1 Overview
    • 10.1.2 North America Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
    • 10.1.3 North America: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 - 2030 (US$ Million)
      • 10.1.3.1 North America: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
      • 10.1.3.2 North America: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
    • 10.1.4 North America: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 - 2030 (US$ Million)
    • 10.1.5 North America: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 - 2030 (US$ Million)
    • 10.1.6 North America Breast Cancer Therapeutics Market, by Country
      • 10.1.6.1 US
        • 10.1.6.1.1 US Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.6.1.2 US: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.1.6.1.2.1 US: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.1.6.1.2.2 US: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.1.6.1.3 US: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 - 2030 (US$ Million)
        • 10.1.6.1.4 US: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 - 2030 (US$ Million)
      • 10.1.6.2 Canada
        • 10.1.6.2.1 Canada Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.6.2.2 Canada: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.1.6.2.2.1 Canada: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.1.6.2.2.2 Canada: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.1.6.2.3 Canada: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 - 2030 (US$ Million)
        • 10.1.6.2.4 Canada: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 - 2030 (US$ Million)
      • 10.1.6.3 Mexico
        • 10.1.6.3.1 Mexico Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.6.3.2 Mexico: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.1.6.3.2.1 Mexico: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.1.6.3.2.2 Mexico: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.1.6.3.3 Mexico: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 - 2030 (US$ Million)
        • 10.1.6.3.4 Mexico: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 - 2030 (US$ Million)
  • 10.2 Europe Breast Cancer Therapeutics Market, Revenue and Forecast to 2030
    • 10.2.1 Overview
    • 10.2.2 Europe Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
    • 10.2.3 Europe: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 - 2030 (US$ Million)
      • 10.2.3.1 Europe: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
      • 10.2.3.2 Europe: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
    • 10.2.4 Europe: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 - 2030 (US$ Million)
    • 10.2.5 Europe: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 - 2030 (US$ Million)
    • 10.2.6 Europe Breast Cancer Therapeutics Market, by Country
      • 10.2.6.1 UK
        • 10.2.6.1.1 UK Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.6.1.2 UK: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.2.6.1.2.1 UK: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.2.6.1.2.2 UK: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.2.6.1.3 UK: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 - 2030 (US$ Million)
        • 10.2.6.1.4 UK: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 - 2030 (US$ Million)
      • 10.2.6.2 Germany
        • 10.2.6.2.1 Germany Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.6.2.2 Germany: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.2.6.2.2.1 Germany: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.2.6.2.2.2 Germany: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.2.6.2.3 Germany: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 - 2030 (US$ Million)
        • 10.2.6.2.4 Germany: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 - 2030 (US$ Million)
      • 10.2.6.3 France
        • 10.2.6.3.1 France Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.6.3.2 France: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.2.6.3.2.1 France: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.2.6.3.2.2 France: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.2.6.3.3 France: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 - 2030 (US$ Million)
        • 10.2.6.3.4 France: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 - 2030 (US$ Million)
      • 10.2.6.4 Italy
        • 10.2.6.4.1 Italy Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.6.4.2 Italy: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.2.6.4.2.1 Italy: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.2.6.4.2.2 Italy: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.2.6.4.3 Italy: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 - 2030 (US$ Million)
        • 10.2.6.4.4 Italy: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 - 2030 (US$ Million)
      • 10.2.6.5 Spain
        • 10.2.6.5.1 Spain Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.6.5.2 Spain: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.2.6.5.2.1 Spain: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.2.6.5.2.2 Spain: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.2.6.5.3 Spain: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 - 2030 (US$ Million)
        • 10.2.6.5.4 Spain: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 - 2030 (US$ Million)
      • 10.2.6.6 Rest of Europe
        • 10.2.6.6.1 Rest of Europe Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.6.6.2 Rest of Europe: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.2.6.6.2.1 Rest of Europe: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.2.6.6.2.2 Rest of Europe: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.2.6.6.3 Rest of Europe: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 - 2030 (US$ Million)
        • 10.2.6.6.4 Rest of Europe: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 - 2030 (US$ Million)
  • 10.3 Asia Pacific Breast Cancer Therapeutics Market, Revenue and Forecast to 2030
    • 10.3.1 Overview
    • 10.3.2 Asia Pacific Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
    • 10.3.3 Asia Pacific: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 - 2030 (US$ Million)
      • 10.3.3.1 Asia Pacific: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
      • 10.3.3.2 Asia Pacific: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
    • 10.3.4 Asia Pacific: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 - 2030 (US$ Million)
    • 10.3.5 Asia Pacific: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 - 2030 (US$ Million)
    • 10.3.6 Asia Pacific Breast Cancer Therapeutics Market, by Country
      • 10.3.6.1 China
        • 10.3.6.1.1 China Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.6.1.2 China: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.3.6.1.2.1 China: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.3.6.1.2.2 China: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.3.6.1.3 China: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 - 2030 (US$ Million)
        • 10.3.6.1.4 China: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 - 2030 (US$ Million)
      • 10.3.6.2 Japan
        • 10.3.6.2.1 Japan Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.6.2.2 Japan: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.3.6.2.2.1 Japan: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.3.6.2.2.2 Japan: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.3.6.2.3 Japan: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 - 2030 (US$ Million)
        • 10.3.6.2.4 Japan: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 - 2030 (US$ Million)
      • 10.3.6.3 India
        • 10.3.6.3.1 India Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.6.3.2 India: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.3.6.3.2.1 India: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.3.6.3.2.2 India: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.3.6.3.3 India: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 - 2030 (US$ Million)
        • 10.3.6.3.4 India: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 - 2030 (US$ Million)
      • 10.3.6.4 Australia
        • 10.3.6.4.1 Australia Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.6.4.2 Australia: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.3.6.4.2.1 Australia: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.3.6.4.2.2 Australia: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.3.6.4.3 Australia: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 - 2030 (US$ Million)
        • 10.3.6.4.4 Australia: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 - 2030 (US$ Million)
      • 10.3.6.5 South Korea
        • 10.3.6.5.1 South Korea Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.6.5.2 South Korea: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.3.6.5.2.1 South Korea: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.3.6.5.2.2 South Korea: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.3.6.5.3 South Korea: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 - 2030 (US$ Million)
        • 10.3.6.5.4 South Korea: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 - 2030 (US$ Million)
      • 10.3.6.6 Rest of Asia Pacific
        • 10.3.6.6.1 Rest of Asia Pacific Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.6.6.2 Rest of Asia Pacific: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.3.6.6.2.1 Rest of Asia Pacific: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.3.6.6.2.2 Rest of Asia Pacific: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.3.6.6.3 Rest of Asia Pacific: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 - 2030 (US$ Million)
        • 10.3.6.6.4 Rest of Asia Pacific: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 - 2030 (US$ Million)
  • 10.4 Middle East & Africa Breast Cancer Therapeutics Market, Revenue and Forecast to 2030
    • 10.4.1 Overview
    • 10.4.2 Middle East & Africa Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
    • 10.4.3 Middle East & Africa: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 - 2030 (US$ Million)
      • 10.4.3.1 Middle East & Africa: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
      • 10.4.3.2 Middle East & Africa: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
    • 10.4.4 Middle East & Africa: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 - 2030 (US$ Million)
    • 10.4.5 Middle East & Africa: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 - 2030 (US$ Million)
    • 10.4.6 Middle East & Africa Breast Cancer Therapeutics Market, by Country
      • 10.4.6.1 Saudi Arabia
        • 10.4.6.1.1 Saudi Arabia Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.6.1.2 Saudi Arabia: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.4.6.1.2.1 Saudi Arabia: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.4.6.1.2.2 Saudi Arabia: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.4.6.1.3 Saudi Arabia: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 - 2030 (US$ Million)
        • 10.4.6.1.4 Saudi Arabia: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 - 2030 (US$ Million)
      • 10.4.6.2 UAE
        • 10.4.6.2.1 UAE Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.6.2.2 UAE: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.4.6.2.2.1 UAE: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.4.6.2.2.2 UAE: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.4.6.2.3 UAE: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 - 2030 (US$ Million)
        • 10.4.6.2.4 UAE: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 - 2030 (US$ Million)
      • 10.4.6.3 South Africa
        • 10.4.6.3.1 South Africa Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.6.3.2 South Africa: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.4.6.3.2.1 South Africa: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.4.6.3.2.2 South Africa: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.4.6.3.3 South Africa: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 - 2030 (US$ Million)
        • 10.4.6.3.4 South Africa: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 - 2030 (US$ Million)
      • 10.4.6.4 Rest of Middle East & Africa
        • 10.4.6.4.1 Rest of Middle East & Africa Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.6.4.2 Rest of Middle East & Africa: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.4.6.4.2.1 Rest of Middle East & Africa: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.4.6.4.2.2 Rest of Middle East & Africa: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.4.6.4.3 Rest of Middle East & Africa: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 - 2030 (US$ Million)
        • 10.4.6.4.4 Rest of Middle East & Africa: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 - 2030 (US$ Million)
  • 10.5 South & Central America Breast Cancer Therapeutics Market, Revenue and Forecast to 2030
    • 10.5.1 Overview
    • 10.5.2 South & Central America Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
    • 10.5.3 South & Central America: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 - 2030 (US$ Million)
      • 10.5.3.1 South & Central America: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
      • 10.5.3.2 South & Central America: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
    • 10.5.4 South & Central America: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 - 2030 (US$ Million)
    • 10.5.5 South & Central America: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 - 2030 (US$ Million)
    • 10.5.6 South & Central America Breast Cancer Therapeutics Market, by Country
      • 10.5.6.1 Brazil
        • 10.5.6.1.1 Brazil Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.5.6.1.2 Brazil: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.5.6.1.2.1 Brazil: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.5.6.1.2.2 Brazil: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.5.6.1.3 Brazil: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 - 2030 (US$ Million)
        • 10.5.6.1.4 Brazil: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 - 2030 (US$ Million)
      • 10.5.6.2 Argentina
        • 10.5.6.2.1 Argentina Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.5.6.2.2 Argentina: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.5.6.2.2.1 Argentina: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.5.6.2.2.2 Argentina: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.5.6.2.3 Argentina: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 - 2030 (US$ Million)
        • 10.5.6.2.4 Argentina: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 - 2030 (US$ Million)
      • 10.5.6.3 Rest of South & Central America
        • 10.5.6.3.1 Rest of South & Central America Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.5.6.3.2 Rest of South & Central America: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.5.6.3.2.1 Rest of South & Central America: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.5.6.3.2.2 Rest of South & Central America: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.5.6.3.3 Rest of South & Central America: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 - 2030 (US$ Million)
        • 10.5.6.3.4 Rest of South & Central America: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 - 2030 (US$ Million)

11. Breast Cancer Therapeutics Market ??Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in Breast Cancer Therapeutics Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Eli Lilly and Co
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Eisai Co Ltd
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Novartis AG
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 AstraZeneca Plc
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Pfizer Inc
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Gilead Sciences Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Merck & Co Inc
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Genentech Inc.
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Teva Pharmaceutical Industries Ltd
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Amgen Inc
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. Breast Cancer Therapeutics Market Segmentation
  • Table 2. Global Breast Cancer Therapeutics Market, by Targeted Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 3. Global Breast Cancer Therapeutics Market, by Hormonal Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 4. North America Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 5. North America Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 6. North America Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 7. North America Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
  • Table 8. North America Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
  • Table 9. US Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 10. US Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 11. US Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 12. US Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
  • Table 13. US Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
  • Table 14. Canada Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 15. Canada Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 16. Canada Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 17. Canada Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
  • Table 18. Canada Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
  • Table 19. Mexico Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 20. Mexico Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 21. Mexico Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 22. Mexico Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
  • Table 23. Mexico Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
  • Table 24. Europe Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 25. Europe Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 26. Europe Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 27. Europe Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
  • Table 28. Europe Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
  • Table 29. UK Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 30. UK Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 31. UK Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 32. UK Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
  • Table 33. UK Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
  • Table 34. Germany Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 35. Germany Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 36. Germany Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 37. Germany Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
  • Table 38. Germany Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
  • Table 39. France Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 40. France Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 41. France Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 42. France Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
  • Table 43. France Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
  • Table 44. Italy Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 45. Italy Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 46. Italy Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 47. Italy Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
  • Table 48. Italy Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
  • Table 49. Spain Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 50. Spain Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 51. Spain Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 52. Spain Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
  • Table 53. Spain Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
  • Table 54. Rest of Europe Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 55. Rest of Europe Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 56. Rest of Europe Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 57. Rest of Europe Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
  • Table 58. Rest of Europe Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
  • Table 59. Asia Pacific Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 60. Asia Pacific Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 61. Asia Pacific Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 62. Asia Pacific Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
  • Table 63. Asia Pacific Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
  • Table 64. China Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 65. China Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 66. China Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 67. China Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
  • Table 68. China Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
  • Table 69. Japan Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 70. Japan Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 71. Japan Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 72. Japan Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
  • Table 73. Japan Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
  • Table 74. India Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 75. India Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 76. India Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 77. India Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
  • Table 78. India Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
  • Table 79. Australia Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 80. Australia Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 81. Australia Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 82. Australia Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
  • Table 83. Australia Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
  • Table 84. South Korea Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 85. South Korea Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 86. South Korea Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 87. South Korea Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
  • Table 88. South Korea Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
  • Table 89. Rest of Asia Pacific Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 90. Rest of Asia Pacific Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 91. Rest of Asia Pacific Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 92. Rest of Asia Pacific Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
  • Table 93. Rest of Asia Pacific Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
  • Table 94. Middle East & Africa Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 95. Middle East & Africa Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 96. Middle East & Africa Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 97. Middle East & Africa Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
  • Table 98. Middle East & Africa Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
  • Table 99. Saudi Arabia Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 100. Saudi Arabia Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 101. Saudi Arabia Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 102. Saudi Arabia Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
  • Table 103. Saudi Arabia Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
  • Table 104. UAE Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 105. UAE Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 106. UAE Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 107. UAE Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
  • Table 108. UAE Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
  • Table 109. South Africa Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 110. South Africa Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 111. South Africa Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 112. South Africa Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
  • Table 113. South Africa Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
  • Table 114. Rest of Middle East & Africa Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 115. Rest of Middle East & Africa Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 116. Rest of Middle East & Africa Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 117. Rest of Middle East & Africa Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
  • Table 118. Rest of Middle East & Africa Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
  • Table 119. South & Central America Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 120. South & Central America Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 121. South & Central America Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 122. South & Central America Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
  • Table 123. South & Central America Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
  • Table 124. Brazil Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 125. Brazil Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 126. Brazil Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 127. Brazil Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
  • Table 128. Brazil Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
  • Table 129. Argentina Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 130. Argentina Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 131. Argentina Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 132. Argentina Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
  • Table 133. Argentina Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
  • Table 134. Rest of South & Central America Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 135. Rest of South & Central America Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 136. Rest of South & Central America Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 137. Rest of South & Central America Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
  • Table 138. Rest of South & Central America Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
  • Table 139. Recent Organic Growth Strategies in Breast Cancer Therapeutics Market
  • Table 140. Recent Inorganic Growth Strategies in the Breast Cancer Therapeutics Market
  • Table 141. Glossary of Terms, Breast Cancer Therapeutics Market

List Of Figures

  • Figure 1. Breast Cancer Therapeutics Market Segmentation, By Geography
  • Figure 2. Global - PEST Analysis
  • Figure 3. Breast Cancer Therapeutics Market - Key Industry Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. Breast Cancer Therapeutics Market Revenue (US$ Mn), 2022 2030
  • Figure 6. Breast Cancer Therapeutics Market Revenue Share, by Drug Therapy, 2022 & 2030 (%)
  • Figure 7. Targeted Drug Therapy: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Hormonal Drug Therapy: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Chemotherapy: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Immunotherapy/ Biological Therapy: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Breast Cancer Therapeutics Market Revenue Share, by Breast Cancer Type, 2022 & 2030 (%)
  • Figure 12. Hormone Receptor: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. HER2+: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Triple-Negative Breast Cancer: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Breast Cancer Therapeutics Market Revenue Share, by Distribution Channel, 2022 & 2030 (%)
  • Figure 16. Hospital Pharmacies: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Drug Store and Retail Pharmacies: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Online Pharmacies: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. North America: Breast Cancer Therapeutics Market, by Key Country Revenue (2022) (US$ Million)
  • Figure 20. North America Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 21. North America Breast Cancer Therapeutics Market, By Key Countries, 2022 and 2030 (%)
  • Figure 22. US Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 23. Canada Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 24. Mexico Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 25. Europe Breast Cancer Therapeutics Market, by Key Country Revenue, 2022 (US$ Million)
  • Figure 26. Europe Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 27. Europe Breast Cancer Therapeutics Market, By Key Countries, 2022 and 2030 (%)
  • Figure 28. UK Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 29. Germany Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 30. France Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 31. Italy Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 32. Spain Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 33. Rest of Europe Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 34. Asia Pacific Breast Cancer Therapeutics Market, by Key Country Revenue, 2022 (US$ Million)
  • Figure 35. Asia Pacific Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 36. Asia Pacific Breast Cancer Therapeutics Market, By Key Countries, 2022 and 2030 (%)
  • Figure 37. China Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 38. Japan Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 39. India Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 40. Australia Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 41. South Korea Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 42. Rest of Asia Pacific Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 43. Middle East & Africa Breast Cancer Therapeutics Market, by Key Country Revenue, 2022 (US$ Million)
  • Figure 44. Middle East & Africa Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 45. Middle East & Africa Breast Cancer Therapeutics Market, By Key Countries, 2022 and 2030 (%)
  • Figure 46. Saudi Arabia Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 47. UAE Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 48. South Africa Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 49. Rest of Middle East & Africa Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 50. South & Central America Breast Cancer Therapeutics Market, by Key Country Revenue, 2022 (US$ Million)
  • Figure 51. South & Central America Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 52. South & Central America Breast Cancer Therapeutics Market, By Key Countries, 2022 and 2030 (%)
  • Figure 53. Brazil Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 54. Argentina Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 55. Rest of South & Central America Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 56. Growth Strategies in Breast Cancer Therapeutics Market